Wells Fargo & Company Opti Nose, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Opti Nose, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 250 shares of OPTN stock, worth $92. This represents 0.0% of its overall portfolio holdings.

Number of Shares

250

Previous 465 46.24%

Holding current value

$92

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.67 - $1.27 $144 - $273	-215 Reduced 46.24%	250 $0
Q2 2024 Aug 13, 2024	SELL	$0.82 - $1.44 $17,722 - $31,122	-21,613 Reduced 97.89%	465 $0
Q1 2024 May 10, 2024	BUY	$1.17 - $1.94 $3,417 - $5,666	2,921 Added 15.25%	22,078 $32,000
Q4 2023 Feb 09, 2024	BUY	$1.02 - $1.47 $4,388 - $6,323	4,302 Added 28.96%	19,157 $24,000
Q3 2023 Nov 13, 2023	SELL	$0.93 - $1.38 $14,760 - $21,903	-15,872 Reduced 51.65%	14,855 $18,000
Q2 2023 Aug 15, 2023	BUY	$1.11 - $2.05 $33,222 - $61,356	29,930 Added 3755.33%	30,727 $37,000
Q1 2023 May 12, 2023	BUY	$1.63 - $2.02 $326 - $404	200 Added 33.5%	797 $1,000
Q4 2022 Feb 13, 2023	SELL	$1.68 - $3.7 $29,060 - $64,002	-17,298 Reduced 96.66%	597 $1,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $4.01 $59,040 - $69,024	17,213 Added 2523.9%	17,895 $65,000
Q2 2022 Aug 12, 2022	BUY	$1.76 - $3.82 $760 - $1,650	432 Added 172.8%	682 $3,000
Q4 2021 Feb 14, 2022	SELL	$1.55 - $3.1 $333 - $666	-215 Reduced 46.24%	250 $0
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.16 $39 - $53	-17 Reduced 3.53%	465 $2,000
Q2 2021 Aug 16, 2021	SELL	$2.91 - $3.83 $31,308 - $41,206	-10,759 Reduced 95.71%	482 $2,000
Q1 2021 May 13, 2021	SELL	$3.47 - $4.75 $199,826 - $273,538	-57,587 Reduced 83.67%	11,241 $41,000
Q4 2020 Feb 09, 2021	BUY	$3.2 - $4.98 $58,230 - $90,621	18,197 Added 35.94%	68,828 $286,000
Q3 2020 Nov 05, 2020	SELL	$3.69 - $7.09 $45,449 - $87,327	-12,317 Reduced 19.57%	50,631 $197,000
Q2 2020 Aug 13, 2020	BUY	$3.58 - $7.44 $59,549 - $123,756	16,634 Added 35.92%	62,948 $469,000
Q1 2020 May 14, 2020	BUY	$3.49 - $9.2 $161,635 - $426,088	46,314 New	46,314 $208,000

Others Institutions Holding OPTN

# of Institutions

Shares Held

88.3M

Call Options Held

Put Options Held

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $30.8M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Opti Nose, Inc. Transaction History